Financial statements Apteka Eskulap
Balance sheet data of APTEKA ESKULAP
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 481 973,61 | 545 680,87 | 631 875,79 | 595 386,92 | 608 000,67 | 681 147,48 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| B. Current assets | 481 973,61 | 545 680,87 | 631 875,79 | 595 386,92 | 608 000,67 | 681 147,48 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 481 973,61 | 545 680,87 | 631 875,79 | 595 386,92 | 608 000,67 | 681 147,48 |
| A. Equity | -161 996,57 | -321 626,97 | -429 917,33 | -462 725,70 | -489 795,77 | -589 892,11 |
| B. Liabilities and provisions for liabilities | 643 970,18 | 867 307,84 | 1 061 793,12 | 1 058 112,62 | 1 097 796,44 | 1 271 039,59 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| II. Short-term liabilities | 643 970,18 | 867 307,84 | 1 061 793,12 | 1 058 112,62 | 1 097 796,44 | 1 271 039,59 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.